SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1094The VX-222+Telaprevir phase-2 trial is notable in several ways: siliconinvestorDewDiligence_on_SI-3/1/2010
1093Vertex Pharmaceuticals Announces Redemption Date for 4.75% Convertible Senior Sutnsaf-2/17/2010
1092Tara Kieffer: From helix to hepatitis <i>[Profile from TheScientist] the-tnsaf-1/30/2010
1091Today’s VRTX PR has <i>five</i> timeline changes/slippages: siliconDewDiligence_on_SI11/10/2010
1090presenting 2:30 p.m. (Pacific), Tuesday 12 January at JP Morgan.scaram(o)uche-12/11/2009
1089Vertex Pharmaceuticals Announces Pricing of Public Offering of Common Stock - 1tnsaf-12/3/2009
1088thestreet.com As I alluded to in my last post to you, we're now starting toCasaubon-11/17/2009
1087<i>Why do you say that?</i> because the response is too low to be aCasaubon-11/3/2009
1086<i> This bodes well for VRTX, IMO.</i> Why do you say that? I thinghmm111/3/2009
1085finance.yahoo.com The full dose combination of <b>RG7128 1000mg and RG722Casaubon-11/3/2009
1084<i>It looks like the once a day regime for narlaprevir is accomplished by tnsaf-11/2/2009
1083UPDATE 1-Once-daily Schering hepatitis C drug shows promise Mon Nov 2, 2009 5:30tnsaf-11/2/2009
1082Here’s a “prettified” table from the C208 study to use as a reference while listDewDiligence_on_SI111/1/2009
1081finance.yahoo.com <i>Webcast at 7:00 p.m. ET on Sunday, November 1, 2009 scaram(o)uche-10/31/2009
1080reuters.com Vertex hep C drug works well in twice daily dosing Sat Oct 31, 2009scaram(o)uche110/31/2009
1079Your post came in 5 seconds before mine :-)DewDiligence_on_SI-10/27/2009
1078VRTX 3Q09 CC notes: siliconinvestor.comDewDiligence_on_SI-10/27/2009
1077Vertex Pharmaceuticals Reports Third Quarter 2009 Financial Results and Highlightnsaf-10/27/2009
1076Message 26027277scaram(o)uche-10/17/2009
1075Emmens has substantial commercial experience himself.idos-10/2/2009
1074AASLD abstracts are out.idos110/1/2009
1073Vertex Pharmaceuticals Provides Corporate Update -Vertex announces plans to initnsaf-9/30/2009
1072Vertex Pharmaceuticals to Receive $155 Million in Cash Related to Future Telapretnsaf-9/30/2009
1071Kurt Graves has left the building: siliconinvestor.com Comments?DewDiligence_on_SI-9/30/2009
1070That's about what i would expect as a fair price given a small risk and timerkrw-7/10/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News